- Home
- MNKD vs EVV Comparison
MNKD vs EVV Comparison
Compare MNKD & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- EVV
- Stock Information
- Founded
- MNKD 1991
- EVV 2003
- Country
- MNKD United States
- EVV United States
- Employees
- MNKD N/A
- EVV N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- EVV Finance/Investors Services
- Sector
- MNKD Health Care
- EVV Finance
- Exchange
- MNKD Nasdaq
- EVV Nasdaq
- Market Cap
- MNKD 1.2B
- EVV 1.2B
- IPO Year
- MNKD 2004
- EVV N/A
- Fundamental
- Price
- MNKD $3.73
- EVV $10.13
- Analyst Decision
- MNKD Buy
- EVV
- Analyst Count
- MNKD 6
- EVV 0
- Target Price
- MNKD $9.17
- EVV N/A
- AVG Volume (30 Days)
- MNKD 3.1M
- EVV 323.7K
- Earning Date
- MNKD 08-06-2025
- EVV 01-01-0001
- Dividend Yield
- MNKD N/A
- EVV 9.66%
- EPS Growth
- MNKD 149.32
- EVV N/A
- EPS
- MNKD 0.11
- EVV N/A
- Revenue
- MNKD $301,736,000.00
- EVV N/A
- Revenue This Year
- MNKD $13.62
- EVV N/A
- Revenue Next Year
- MNKD $15.18
- EVV N/A
- P/E Ratio
- MNKD $34.33
- EVV N/A
- Revenue Growth
- MNKD 21.48
- EVV N/A
- 52 Week Low
- MNKD $3.38
- EVV $8.52
- 52 Week High
- MNKD $7.63
- EVV $10.07
- Technical
- Relative Strength Index (RSI)
- MNKD 48.69
- EVV 49.72
- Support Level
- MNKD $3.60
- EVV $10.07
- Resistance Level
- MNKD $3.81
- EVV $10.14
- Average True Range (ATR)
- MNKD 0.17
- EVV 0.06
- MACD
- MNKD -0.00
- EVV 0.00
- Stochastic Oscillator
- MNKD 50.72
- EVV 63.16
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest
Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.